METiS 杭州剂泰医药宣布获数百万美元天使轮融资

METiS 杭州剂泰医药宣布获数百万美元天使轮融资
本轮融资后公司将同步搭建中、美两地 AI 制剂优化平台，并与国内外合作药企推进制剂新药管
线研发及临床前制剂开发 … METiS 是一家以人工智能驱动药物制剂开发的新创公司，致力以高
通量制剂平台及人工智能计算等技术，为药企提供快速、精确的智能化制剂研发，并在癌症、传
染性疾病等领域开发制剂新药，为患者带来优质高效的药物 … 依托自主开发的药物大数据计算/
实验平台以及创始团队深厚的制药经验积累，METiS 能有效利用人工智能整合制剂实验及计算
平台推动药物制剂的全局优化，以提升新药开发效能, 并打造具临床差异化的制剂新药管线
Metis Hangzhou Pharmaceutical Co., Ltd. announced the angel round financing of millions of dollars
After this round of financing, the company will simultaneously build the AI preparation optimization platform in China and the United States, and promote the new preparation management with domestic and foreign cooperative pharmaceutical enterprises
Metis is a new company that drives the development of pharmaceutical preparations with artificial intelligence. Metis is committed to
Flux preparation platform and artificial intelligence computing technology provide pharmaceutical companies with rapid and accurate intelligent preparation research and development, and in cancer, transmission
Development of new drugs in infectious diseases and other fields, bringing high-quality and efficient drugs to patients/
Metis can effectively utilize artificial intelligence to integrate the experiment and calculation of pharmaceutical products based on the deep pharmaceutical experience of the experimental platform and the founding team
The platform promotes the overall optimization of pharmaceutical preparations, improves the efficiency of new drug development, and creates a new drug pipeline with clinical differentiation